Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 2, 1997, Pages 283-286

  Versalovic, James ^a,c   Osato, Michael S ^a   Spakovsky, Klaudia ^a   Dore, Maria Pina ^a   Reddy, Rita ^a   Stone, Gregory G ^b   Shortridge, Dee ^b   Flamm, Robert K ^b   Tanaka, S Ken ^b   Graham, David Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIC ULCER; POINT MUTATION; RECURRENT DISEASE; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; HELICOBACTER PYLORI; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S;

EID: 0030770494     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.2.283     Document Type: Article

References (9)

1. Logan, R. P. H., Gummett, P. A., Schaufelberger, H. D., Greaves, R. R. F. H., Mendelson, G. M., Walker, M. M. et al. (1994). Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 35, 323-6.
2. Cayla, R., Zerbib, F., Talbi, P., Mégraud, F. & Lamouliatte, H. (1995). Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 37, Suppl. 1, A55.
3. Xia, H. X., Buckley, M., Hyde, D., Keane, C. T. & O'Morain, C. A. (1995). Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 37, Suppl. 1, A55.
4. Versalovic, J., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J., Flamm, R. K. et al. (1996). Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy 40, 477-80.
5. Debets-Ossenkopp, Y. J., Sparrius, M., Kusters, J. G., Kolkman, J. J. & Vandenbroucke-Grauls, C. M. J. E. (1996). Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiology Letters 142, 37-42.
6. Hachem, C. Y., Clarridge, J. E., Reddy, R., Flamm, R., Evans, D. G., Tanaka, S. K. et al. (1996). Antimicrobial susceptibility testing of Helicobacter pylori - comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagnostic Microbiology and Infectious Disease 24, 37-41.
7. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition; Approved Standard M7-A3. NCCLS, Villanova, PA.
8. Meier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J. et al. (1994). Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 38, 381-4.
9. Stone, G. G., Shortridge, D., Flamm, R. K., Versalovic, J., Beyer, J., Idler, K. et al. (1996). Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1, 227-8.